bioRxivMolecular BiologyPreprint
Japanese Encephalitis Virus: A pan-proteome analysis for aggregation propensities and in vitro validation with Capsid anchor and 2K peptide
Kumar Udit Saumya, Taniya Bharadwaj, Duni Chand Thakur, Deepanshu Verma, Rajanish GiriiD
Abstract
Japanese encephalitis infection is a vector-borne disease caused by the flavivirus Japanese encephalitis virus (JEV). It is responsible of severe brain infection in humans worldwide. Given the ubiquitous nature of complications and tropism associated with Japanese encephalitis (JE) infection, a holistic understanding of its molecular mechanism is essential. The phenomenon of abnormal protein aggregation into pathogenic amyloids is now increasingly linked to multiple human diseases, also known as Amyloidosis. Most are neurodegenerative disorders but amyloidosis is not restricted to a specific organ or tissue type. The overlap of viral protein aggregation with human pathologies remains limited and it is gaining momentum, especially after the devastating Covid-19 pandemic. Therefore, in this study we have examined the likelihood of aggregation for the entire collection of proteins in JEV. Multiple independent web server tools were employed to scan for potential amyloid prone-regions (APRs), and it was followed by in vitro validation using two JEV transmembrane domains, Capsid anchor and 2K peptides. These synthetic viral peptides were introduced to artificial aggregation-inducing conditions and then analyzed using a different dye-based assays and microscopy methods confirming amyloid-like fibril structure formation. We found these aggregates cytotoxic to human neuronal cell line and membrane damaging to human blood derived RBCs. The aggregation kinetics of both peptides is enhanced in the presence of artificial membrane models and seeds of self and diabetes hallmark protein Amylin. Our findings thereby strongly suggest the possibility of JEV protein aggregation playing a vital role in its pathogenesis, opening up a broad scope of future study. Also, the interplay between JEV protein aggregation and initiation/progression of other proteopathies is possible and needs further exploration. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=116 SRC="FIGDIR/small/556571v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@2956d0org.highwire.dtl.DTLVardef@28128org.highwire.dtl.DTLVardef@6d7faaorg.highwire.dtl.DTLVardef@d89f40_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The aggregation potential of Zika virus proteome
R. Giri, T. Bhardwaj, … N. Sharma·bioRxiv·Mar 26, 2022
- Zika Virus Capsid Anchor Forms Cytotoxic Amyloid-like Fibrils
K. U. Saumya, K. Gadhave, … R. Giri·bioRxiv·Nov 13, 2020
- Endophilin mediated endocytosis and Epidermal growth factor receptor govern Japanese encephalitis virus entry and infection in neuronal cells
Puja Sharma, Mukesh Tanwar, … Manjula Kalia·PLoS PathogensPeer-reviewed·Dec 16, 2025
- Deep proteomics network and machine learning analysis of human cerebrospinal fluid in Japanese encephalitis virus infection
T. Bharucha, B. Gangadharan, … SEAe collaborators·bioRxiv·Jun 19, 2022
- Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine strains in an in cellulo model of human blood-brain barrier
C. Khou, M. A. Diaz-Salinas, … N. Pardigon·bioRxiv·May 19, 2019
- Amyloidogenesis of SARS-CoV-2 Spike Protein
S. Nystrom, P. Hammarstrom·bioRxiv·Dec 16, 2021